The current ibuprofen/kneeguard pilot study says a future large randomised clinical trial will be conducted. How long does the board realistically anticipate before having drug patch products on the shelves?
Given this is an OBJ-developed invention and the board has said it will attract significantly higher royalties, what percentage royalties are you targeting in your business plan?
Questions for Investor Call, page-18
-
- There are more pages in this discussion • 90 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add WFL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| WFL (ASX) Chart |
Day chart unavailable